Compounds of Formula (I) or pharmaceutically acceptable salts or N-oxides thereof:
(relative chemistry shown) pharmaceutical compositions comprising them, their use in therapy especially against tuberculosis, and methods of preparing them are described.
[EN] TRICYCLIC NITROGEN CONTAINING COMPOUNDS AND THEIR USE AS ANTIBACTERIALS<br/>[FR] COMPOSÉS CONTENANT DE L'AZOTE TRICYCLIQUE ET UTILISATION DE CEUX-CI COMME ANTIBACTÉRIENS
申请人:GLAXO GROUP LTD
公开号:WO2009141399A1
公开(公告)日:2009-11-26
Compounds of Formula (I) or a pharmaceutically acceptable salt or N-oxide thereof; Formula (I) (relative stereochemistry shown) wherein: Z1, Z2 , L are as defined, U represents a cyclic group selected from: phenyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, thiazolyl, furanyl, imidazolyl and thiophenyl; m is 0 or 1, n is independently 0 or 1; and substituent(s) R5 and R6 are independently selected from: halo, CF3, OCF3, C1_3 alkyl, C1_3 alkoxy, nitro and cyano. Compounds of Formula (I) have anti -tuberculosis and antibacterial activity.
[EN] NEW ANTIBACTERIAL COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS ANTIBACTÉRIENS
申请人:ACRAF
公开号:WO2017211759A1
公开(公告)日:2017-12-14
The present invention relates to novel antibacterial compounds, pharmaceutical compositions containing them and their use as antimicrobials.
这项发明涉及新型抗菌化合物,含有它们的药物组合物以及它们作为抗微生物药物的用途。
[EN] TRICYCLIC NITROGEN COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS<br/>[FR] COMPOSÉS AZOTÉS TRICYCLIQUES ET LEUR UTILISATION COMME AGENTS ANTIBACTÉRIENS
申请人:GLAXO GROUP LTD
公开号:WO2009087153A1
公开(公告)日:2009-07-16
Tricyclic nitrogen containing compounds and their use as antibacterials.
三环氮含有化合物及其作为抗菌剂的用途。
[EN] TRICYCLIC NITROGEN CONTAINING COMPOUNDS FOR TREATING NEISSERIA GONORRHOEA INFECTION<br/>[FR] COMPOSÉS CONTENANT DE L'AZOTE TRICYCLIQUE POUR LE TRAITEMENT DE L'INFECTION À NEISSERIA GONORRHOEAE
申请人:GLAXOSMITHKLINE IP DEV LTD
公开号:WO2016027249A1
公开(公告)日:2016-02-25
The present invention relates to methods for treating Neisseria gonorrhoeae infection which comprises administering to a subject in need thereof novel Tricyclic nitrogen containing compounds and corresponding pharmaceutical compositions as described herein.